• Explore /
  • Poster
  • / A phase I/II study of cetuximab (cet) in combination with S-1 and oxaliplatin (SOX) in first-line treatment for metastatic colorectal cancer (mCRC) (JACCRO CC-06).

A phase I/II study of cetuximab (cet) in combination with S-1 and oxaliplatin (SOX) in first-line treatment for metastatic colorectal cancer (mCRC) (JACCRO CC-06).

Abstract Poster

Authors

null

Akihito Tsuji

Kobe City Medical Center General Hospital, Kobe, Japan

Akihito Tsuji , Yu Sunakawa , Tadamichi Denda , Yasutaka Takinishi , Masahito Kotaka , Hiroaki Tanioka , Ken Shimada , Mitsugu Kochi , Takanori Watanabe , Masato Nakamura , Hiroto Ueda , Michio Inukai , Toshiki Masuishi , Satoshi Tani , Yuji Negoro , Tatsuya Okuno , Masahiro Takeuchi , Wataru Ichikawa , Masashi Fujii , Toshifusa Nakajima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000007022

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 571)

DOI

10.1200/jco.2014.32.3_suppl.571

Abstract #

571

Poster Bd #

D20

Abstract Disclosures

Similar Posters

First Author: Shigenori Kadowaki

First Author: Jean Alfred Maroun

First Author: Li-Tzong Chen

First Author: Antoine Adenis